Mapi has subsidiaries in Asia, Europe, and Israel. The group is currently building its first intermediates and API production site in Israel’s designated chemical park in Ramat Hovav, and is in the process of establishing its presence in one of China’s chemical parks. The new production facility is being set up in Israel as per ICH, US and PIC guidelines, to meet the requirements of USFDA and various European MOHs.
In addition to intermediates and APIs production, the company has formulation labs in Israel and in Germany.